α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression

This study investigated the antidepressant potential of α-tocopherol, the most active and abundant form of vitamin E, in the forced swim test (FST) and tail suspension test (TST). The acute oral treatment with α-tocopherol at the doses of 30 and 100 mg/kg reduced the immobility time in the FST and i...

Full description

Saved in:
Bibliographic Details
Published in:Behavioural brain research Vol. 209; no. 2; pp. 249 - 259
Main Authors: Lobato, Kelly R., Cardoso, Chandra C., Binfaré, Ricardo W., Budni, Josiane, Wagner, Cristiane L.R., Brocardo, Patrícia S., de Souza, Luiz Felipe, Brocardo, Caroline, Flesch, Samira, Freitas, Andiara E., Dafré, Alcir L., Rodrigues, Ana Lúcia S.
Format: Journal Article
Language:English
Published: Shannon Elsevier B.V 19-06-2010
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study investigated the antidepressant potential of α-tocopherol, the most active and abundant form of vitamin E, in the forced swim test (FST) and tail suspension test (TST). The acute oral treatment with α-tocopherol at the doses of 30 and 100 mg/kg reduced the immobility time in the FST and in the TST. A single i.c.v. administration of α-tocopheryl phosphate, a water-soluble analogue of α-tocopherol, also reduced the immobility time in the FST (0.1 and 1 nmol/site) and in the TST (0.1 nmol/site). In addition, the long-term treatment (28 days) with α-tocopherol (10 mg/kg, p.o.) significantly reduced the immobility time in the FST. Moreover, a subeffective dose of α-T (10 mg/kg, p.o.) potentiated the effect of fluoxetine (10 mg/kg, p.o.) in the FST. The long-term treatment with α-T was able to increase the glutathione (GSH) antioxidant defense system, while the acute treatment was not. The long-term treatment with α-tocopherol (10 mg/kg) increased the GSH levels in the hippocampus and in the prefrontal cortex and increased the glutathione peroxidase and glutathione reductase activity in the hippocampus (10 mg/kg) and in the prefrontal cortex (10–100 mg/kg). The long-term treatment with fluoxetine (10 mg/kg, p.o.), a positive control, was also able to increase the GSH levels in the hippocampus, but failed to alter the activity of both enzymes. Besides the specific antidepressant-like effect, long-term, but not the acute treatment with α-T, especially in the doses that produced an antidepressant-like effect (10 mg/kg), improved the antioxidant defenses in the mouse hippocampus and prefrontal cortex, two structures closely implicated in the pathophysiology of depression.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0166-4328
1872-7549
DOI:10.1016/j.bbr.2010.02.002